Cargando…
Rich Organic Nitrogen Impacts Clavulanic Acid Biosynthesis through the Arginine Metabolic Pathway in Streptomyces clavuligerus F613-1
Clavulanic acid (CA) is the preferred clinical drug for the treatment of infections by β-lactam antibiotic-resistant bacteria. CA is produced by Streptomyces clavuligerus, and although there have been many reports on the effects of carbon and nitrogen sources on CA production, the mechanisms involve...
Autores principales: | Fu, Jiafang, Xie, Xinru, Zhang, Shaowei, Kang, Ni, Zong, Gongli, Zhang, Peipei, Cao, Guangxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927107/ https://www.ncbi.nlm.nih.gov/pubmed/36515504 http://dx.doi.org/10.1128/spectrum.02017-22 |
Ejemplares similares
-
Complete Genome Sequence of Streptomyces clavuligerus F613-1, an Industrial Producer of Clavulanic Acid
por: Cao, Guangxiang, et al.
Publicado: (2016) -
The two-component system CepRS regulates the cephamycin C biosynthesis in Streptomyces clavuligerus F613-1
por: Fu, Jiafang, et al.
Publicado: (2019) -
The CagRS Two-Component System Regulates Clavulanic Acid Metabolism via Multiple Pathways in Streptomyces clavuligerus F613-1
por: Fu, Jiafang, et al.
Publicado: (2019) -
Overproduction of Clavulanic Acid by UV Mutagenesis of Streptomyces clavuligerus
por: Korbekandi, Hassan, et al.
Publicado: (2010) -
Screening of medium constituents for clavulanic acid production by Streptomyces clavuligerus
por: Rodrigues, Kaio César da Silva, et al.
Publicado: (2018)